SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.52-8.7%Jan 23 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: enervestor who wrote (580)1/25/2000 3:01:00 PM
From: Biomaven  Read Replies (1) of 52153
 
At this point it is very hard to sort out who really has the significant IP in the genome. INCY, HGSI and CRA each claim to have most everything, and they are clearly not all right. INCY, and to a lesser extent HGSI, have had pharmas banging away at their data for a while, and they have contractual agreements with these pharmas that may well turn out to be more significant than their patent claims.

In general, you'll find a generally pro-INCY perspective on SI, perhaps partially due to Rocketman and the VD thread. People generally dislike HGSI, partly because of the hype, and (misguidedly at least in retrospect) have avoided CRA altogether. Everyone here loves MLNM, of course. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News